Document Detail


New method for the detection of reactive oxygen species in anti-tumoural activity of adriamycin: a comparison between hypoxic and normoxic cells.
MedLine Citation:
PMID:  18297605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumour hypoxia plays a role in chemoresistance in several human tumours. However, how hyperbaric oxygen leads to chemotherapeutic gain is unclear. This study investigates the relation of reactive oxygen species (ROS) generation with anti-tumoural effect of adriamycin (ADR) on CCRF-CEM cells under hypoxic (2% O(2)) and normoxic (21% O(2)) conditions. A new method was used to measure intracellular ROS variations through the fluorescence lifetime of 1-pyrenebutyric acid. At 24 h, ADR, probably via semiquinone radical, enhances ROS levels in normoxic cells compared to hypoxic cells. Long-term studies show that ROS are also generated by a second mechanism related to cell functions perturbation. ADR arrests the cell cycle progression both under hypoxia and normoxia, indicating that oxygen and ROS does not influence the DNA damaging activity of ADR. The findings reveal that moderate improvement of ADR cytotoxicity results from higher ROS formation in normoxic cells, leading to elevated induction of cell death.
Authors:
Tareck Rharass; Jean Vigo; Jean-Marie Salmon; Anne-Cecile Ribou
Related Documents :
15136725 - Endogenous no regulates superoxide production at low oxygen concentrations by modifying...
1567225 - The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-media...
3421495 - Effects of nonvolatile agents on oxygen demand and energy status in isolated hepatocytes.
19513905 - Mitochondrial reactive oxygen species originating from romo1 exert an important role in...
8314215 - The cytological spectrum of the monocytoid b-cell reaction: recognition of its large ce...
22218895 - Using 32-cell stage xenopus embryos to probe pcp signaling.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Free radical research     Volume:  42     ISSN:  1071-5762     ISO Abbreviation:  Free Radic. Res.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-25     Completed Date:  2008-05-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423872     Medline TA:  Free Radic Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  124-34     Citation Subset:  IM    
Affiliation:
Université de Perpignan Via Domitia, Institut de Modélisation et d'Analyses en Géo-Environnements et Santé, Perpignan, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Apoptosis / drug effects
Cell Cycle / drug effects
Cell Hypoxia / drug effects
Cell Line, Tumor
Cell Proliferation / drug effects
Cell Survival / drug effects
Cytological Techniques*
DNA Damage / drug effects
Doxorubicin / pharmacology*
Fluorescence
Humans
Oxygen / pharmacology*
Pyrenes / metabolism
Reactive Oxygen Species / metabolism*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Pyrenes; 0/Reactive Oxygen Species; 23214-92-8/Doxorubicin; 3443-45-6/1-pyrenebutyrate; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of a nitroxide antioxidant on ischemia-reperfusion injury in the rat in vivo hind limb mo...
Next Document:  Plasma glutathione levels are independently associated with gamma-glutamyltransferase activity in su...